Osimertinib Impurity 75 CAS CATO-C4X-204575
| CAS No. | CATO-C4X-204575 |
| Molecular Formula | C25H31N7O |
| Molecular Weight | 445.56 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The molecular framework of Osimertinib Impurity 75 (C25H31N7O) is characterized by a steroid core, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
Osimertinib Impurity 75 (CAS CATO-C4X-204575) is a certified pharmaceutical impurity reference standard with the molecular formula C25H31N7O and a molecular weight of 445.56 g/mol.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Osimertinib Impurity 75 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C25H31N7O |
| Molecular Weight | 445.56 g/mol |
| Appearance | Pale yellow to yellow crystalline powder |
| Purity | 97%+ |
| Storage | Store at room temperature, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 14.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 7 |
Related Osimertinib Standards
- Osimertinib Impurity 8 (CAS 1421372-66-8)
- Osimertinib Impurity 116 (CAS CATO-C4X-2045116)
- Osimertinib Impurity 95 (CAS CATO-C4X-204595)
- Osimertinib Impurity 102 (CAS CATO-C4X-2045102)
- Osimertinib Impurity 83 (CAS CATO-C4X-204583)
- Osimertinib Impurity 35 (CAS CATO-C4X-204535)
- Osimertinib Impurity 61 (CAS CATO-C4X-204561)
- Osimertinib Impurity 49 (CAS CATO-C4X-204549)
Recommended Standards
- Palbociclib Impurity 20 (CAS CATO-C3D-1542)
- N-(2-(((5-oxo-2,3-dihydro-5H-thiazolo[2,3-b]quinazolin-3-yl)methyl)thio)phenyl)benzamide (CAS 477868-81-8)
- Upadacitinib Impurity 137 (CAS CATO-C4X-2405137)
- Elbanizine (CAS 110629-41-9)
- Sunitinib Impurity 88 (CAS CATO-C4X-133388)
- Atrasentan Impurity 167 (CAS 1059043-40-1)
- Nemonoxacin Impurity 63 (CAS 951163-62-5)
- 2-Amino-1-(4-(tert-butyl)phenyl)-4,5-dimethyl-1H-pyrrole-3-carbonitrile (CAS 1096939-99-9)
- (3-(Trifluoromethyl)pyridin-4-yl)methanol (CAS 1227598-69-7)
- 1-(1,3-thiazol-2-yl)piperidin-4-one (CAS 1016880-42-4)
- 3-(1-(P-tolyl)ethyl)benzaldehyde (CAS 1190968-78-5)
- N-(2-(Aminomethyl)-5-cyclopropoxyphenyl)methanesulfonamide (CAS 1243440-14-3)
- Calcium eicosanoate (CAS 22302-43-8)
- [5-31]-Semaglutide (CAS CATO-C4X-2226263)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com